Kaleido Biosciences Stock Market Value

KLDO Stock  USD 0.0001  0.00  0.00%   
Kaleido Biosciences' market value is the price at which a share of Kaleido Biosciences trades on a public exchange. It measures the collective expectations of Kaleido Biosciences investors about its performance. Kaleido Biosciences is selling at 1.0E-4 as of the 7th of January 2026; that is No Change since the beginning of the trading day. The stock's open price was 1.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of Kaleido Biosciences and determine expected loss or profit from investing in Kaleido Biosciences over a given investment horizon. Check out Kaleido Biosciences Correlation, Kaleido Biosciences Volatility and Kaleido Biosciences Alpha and Beta module to complement your research on Kaleido Biosciences.
Symbol

Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kaleido Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Kaleido Biosciences 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kaleido Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kaleido Biosciences.
0.00
12/08/2025
No Change 0.00  0.0 
In 30 days
01/07/2026
0.00
If you would invest  0.00  in Kaleido Biosciences on December 8, 2025 and sell it all today you would earn a total of 0.00 from holding Kaleido Biosciences or generate 0.0% return on investment in Kaleido Biosciences over 30 days. Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies More

Kaleido Biosciences Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kaleido Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kaleido Biosciences upside and downside potential and time the market with a certain degree of confidence.

Kaleido Biosciences Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Kaleido Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kaleido Biosciences' standard deviation. In reality, there are many statistical measures that can use Kaleido Biosciences historical prices to predict the future Kaleido Biosciences' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kaleido Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00009850.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.000750.01
Details
Naive
Forecast
LowNextHigh
0.0000020.0001256.67
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Kaleido Biosciences Backtested Returns

Kaleido Biosciences is out of control given 3 months investment horizon. Kaleido Biosciences has Sharpe Ratio of 0.25, which conveys that the firm had a 0.25 % return per unit of risk over the last 3 months. We were able to break down sixteen different technical indicators, which can help you to evaluate if expected returns of 64.35% are justified by taking the suggested risk. Use Kaleido Biosciences Standard Deviation of 697.84, risk adjusted performance of 0.136, and Mean Deviation of 237.57 to evaluate company specific risk that cannot be diversified away. Kaleido Biosciences holds a performance score of 19 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 92.19, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kaleido Biosciences will likely underperform. Use Kaleido Biosciences variance and kurtosis , to analyze future returns on Kaleido Biosciences.

Auto-correlation

    
  0.00  

No correlation between past and present

Kaleido Biosciences has no correlation between past and present. Overlapping area represents the amount of predictability between Kaleido Biosciences time series from 8th of December 2025 to 23rd of December 2025 and 23rd of December 2025 to 7th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kaleido Biosciences price movement. The serial correlation of 0.0 indicates that just 0.0% of current Kaleido Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Kaleido Biosciences lagged returns against current returns

Autocorrelation, which is Kaleido Biosciences pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kaleido Biosciences' pink sheet expected returns. We can calculate the autocorrelation of Kaleido Biosciences returns to help us make a trade decision. For example, suppose you find that Kaleido Biosciences has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Kaleido Biosciences regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kaleido Biosciences pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kaleido Biosciences pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kaleido Biosciences pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Kaleido Biosciences Lagged Returns

When evaluating Kaleido Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kaleido Biosciences pink sheet have on its future price. Kaleido Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kaleido Biosciences autocorrelation shows the relationship between Kaleido Biosciences pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Kaleido Biosciences.
   Regressed Prices   
       Timeline  

Other Information on Investing in Kaleido Pink Sheet

Kaleido Biosciences financial ratios help investors to determine whether Kaleido Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kaleido with respect to the benefits of owning Kaleido Biosciences security.